Company Filing History:
Years Active: 2015
Title: Enej Kuscer: Innovator in Tacrolimus Production
Introduction
Enej Kuscer is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of biotechnology, particularly in the production of tacrolimus, a crucial immunosuppressant drug. His innovative approach involves the use of genetically modified strains to enhance fermentation processes.
Latest Patents
Enej Kuscer holds a patent for a process related to the preparation of tacrolimus. This patent describes the use of genetically modified strains that can improve the fermentation process for the preparation of tacrolimus or its salts and derivatives. The novel genes introduced allow for the biosynthesis of allylmalonyl-CoA, which is essential for polyketide production with an allylmalonyl extender unit. He has 1 patent to his name.
Career Highlights
Enej Kuscer is associated with Lek Pharmaceuticals D.d., a prominent pharmaceutical company in Slovenia. His work at Lek Pharmaceuticals has positioned him as a key player in the development of advanced biotechnological processes. His research and innovations have the potential to significantly impact the pharmaceutical industry.
Collaborations
Enej has collaborated with notable colleagues such as Hrvoje Petkovic and Stefan Fujs. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Enej Kuscer's contributions to the field of biotechnology, particularly in the production of tacrolimus, highlight his role as an influential inventor. His innovative methods and collaborations continue to advance the pharmaceutical industry.